SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-037832
Filing Date
2018-06-14
Accepted
2018-06-14 18:05:29
Documents
2
Period of Report
2018-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1575
2 POA DOCUMENT poa.txt EX-24.3_796594 3755
  Complete submission text file 0001209191-18-037832.txt   6867
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Oren Ilan (Reporting) CIK: 0001643073 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 18900261